19-2430956-CAGGAAGGA-CAGGAAGGAAGGA
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6_Moderate
The NM_032737.4(LMNB2):c.1822-8_1822-5dupTCCT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,607,312 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
LMNB2
NM_032737.4 splice_region, intron
NM_032737.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.320
Publications
0 publications found
Genes affected
LMNB2 (HGNC:6638): (lamin B2) This gene encodes a B type nuclear lamin. The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Mutations in this gene are associated with acquired partial lipodystrophy. [provided by RefSeq, May 2012]
LMNB2 Gene-Disease associations (from GenCC):
- microcephaly 27, primary, autosomal dominantInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- progressive myoclonic epilepsy type 9Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- microcephalyInheritance: AD Classification: MODERATE Submitted by: Franklin by Genoox
- lipodystrophy, partial, acquired, susceptibility toInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- central nervous system malformationInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP6
Variant 19-2430956-C-CAGGA is Benign according to our data. Variant chr19-2430956-C-CAGGA is described in ClinVar as Likely_benign. ClinVar VariationId is 740622.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LMNB2 | ENST00000325327.4 | c.1822-5_1822-4insTCCT | splice_region_variant, intron_variant | Intron 11 of 11 | 1 | NM_032737.4 | ENSP00000327054.3 | |||
| LMNB2 | ENST00000475819.1 | n.48-649_48-648insTCCT | intron_variant | Intron 1 of 1 | 5 | |||||
| LMNB2 | ENST00000532465.1 | n.413+591_413+592insTCCT | intron_variant | Intron 4 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152148Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
39
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000225 AC: 56AN: 248840 AF XY: 0.000230 show subpopulations
GnomAD2 exomes
AF:
AC:
56
AN:
248840
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000209 AC: 304AN: 1455046Hom.: 0 Cov.: 28 AF XY: 0.000228 AC XY: 165AN XY: 724212 show subpopulations
GnomAD4 exome
AF:
AC:
304
AN:
1455046
Hom.:
Cov.:
28
AF XY:
AC XY:
165
AN XY:
724212
show subpopulations
African (AFR)
AF:
AC:
1
AN:
33326
American (AMR)
AF:
AC:
3
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26088
East Asian (EAS)
AF:
AC:
0
AN:
39672
South Asian (SAS)
AF:
AC:
1
AN:
86094
European-Finnish (FIN)
AF:
AC:
8
AN:
53354
Middle Eastern (MID)
AF:
AC:
2
AN:
5398
European-Non Finnish (NFE)
AF:
AC:
282
AN:
1106284
Other (OTH)
AF:
AC:
7
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000256 AC: 39AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
39
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41560
American (AMR)
AF:
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
1
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34
AN:
68000
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lipodystrophy, partial, acquired, susceptibility to;C4225289:Progressive myoclonic epilepsy type 9 Benign:1
Nov 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.